Clinical Trials Browser

Phase 2 × Smoking Cessation × 30 days × Clear all

NCT05081882 2026-02-18

Reducing Tobacco-associated Lung Cancer Risk: A Randomized Clinical Trial of AB-free Kava

Phase 2 Active not recruiting

Smoking, Tobacco Use Disorder, Smoking Cessation